Best Lung Cancer Treatment Hospital in Bangalore

Fuda Cancer Hospital – Lung Cancer Care for Banglore Patients

International care, local support

If you are in Bangalore and looking for advanced lung cancer treatment, you can access care from Fuda Cancer Hospital. Fuda’s main hospital is in Guangzhou, China. In India, Fuda partners with Rekosh Health Care to help patients in cities like Bangalore. Fuda does not run a full hospital in Bangalore, but Bangalore patients can get online consultations, personalised treatment plans and follow-up support. For in-person review and palliative care, Fuda operates two consultation centres in India — Mumbai and Noida.

Advanced Lung Cancer Care for Patients Across Bangalore & Karnataka

A diagnosis of lung cancer can be overwhelming for both patients and their families. Along with the emotional impact of the diagnosis, many questions arise. What type of lung cancer is it? Has it spread? Is surgery the best option? Would targeted therapy or immunotherapy provide better results? Should you seek a second opinion before starting treatment?

For patients living in Bangalore, Mysuru, Mangaluru, Hubballi, Belagavi, Tumakuru, Shivamogga, Ballari, Davanagere, Udupi, Hassan, and other parts of Karnataka, having access to reliable information and expert guidance is essential for making informed treatment decisions.

Lung cancer remains one of the leading causes of cancer-related deaths worldwide. While smoking continues to be the primary risk factor, doctors are increasingly diagnosing lung cancer in individuals who have never smoked. Air pollution, second-hand smoke, occupational exposure, indoor pollution, previous lung diseases, and genetic factors also contribute to the development of lung cancer.

Bangalore is recognised as one of India’s leading healthcare destinations, attracting patients from across Karnataka and neighbouring states. The city offers advanced diagnostic facilities, specialised oncology services, multidisciplinary cancer care, and access to modern treatment technologies. Patients seeking expert review and personalised treatment planning can also benefit from Fuda Cancer Hospital’s collaboration with Rekosh Health Care in India.

One of the greatest challenges with lung cancer is that it often develops silently. During its early stages, symptoms may be absent or resemble common respiratory illnesses such as bronchitis, allergies, or recurrent chest infections. Persistent cough, breathlessness, chest pain, coughing up blood, unexplained weight loss, hoarseness of voice, and repeated lung infections should never be ignored.

Fortunately, remarkable advances in oncology have transformed lung cancer treatment. Modern imaging, molecular diagnostics, targeted therapy, immunotherapy, minimally invasive procedures, and multidisciplinary cancer care now enable doctors to create highly personalised treatment plans based on the type of lung cancer, stage of disease, molecular profile, lung function, and the patient’s overall health.

Fuda Cancer Hospital, with its internationally recognised cancer centre in Guangzhou, China, collaborates with Rekosh Health Care in India to support patients seeking expert consultations, second opinions, personalised treatment planning, and coordinated follow-up care. Patients from Bangalore can upload CT scans, PET-CT images, biopsy reports, pathology findings, molecular testing reports, and previous treatment records for expert review. When an in-person evaluation is required, consultation centres in Mumbai and Noida provide additional support and continuity of care.

Depending on the diagnosis, treatment may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, Cryotherapy, NanoKnife Irreversible Electroporation (IRE), or a carefully planned combination of these approaches. Every treatment recommendation is tailored according to the patient’s diagnosis, stage of disease, lung function, molecular profile, and treatment goals.

This comprehensive guide has been developed specifically for patients from Bangalore and across Karnataka. It explains lung cancer in simple language, discusses symptoms, diagnosis, staging, treatment options, recovery, nutrition, rehabilitation, and answers frequently asked questions to help patients and families make confident healthcare decisions.

Why Lung Cancer Is Becoming a Growing Health Concern in Bangalore

As one of India’s fastest-growing metropolitan cities, Bangalore faces increasing environmental and lifestyle factors that may affect respiratory health. Although smoking remains the leading cause of lung cancer, many patients diagnosed today have never smoked.

Factors such as increasing vehicle emissions, urban air pollution, industrial exposure, passive smoking, and occupational hazards may contribute to lung cancer risk alongside genetic susceptibility.

Smoking and Tobacco Use

Smoking cigarettes, beedis, cigars, hookah, and other tobacco products remains the most significant cause of lung cancer.

Tobacco smoke contains thousands of harmful chemicals, many of which damage the DNA of lung cells. Continuous exposure over several years substantially increases the likelihood of developing lung cancer.

Although quitting smoking significantly lowers future risk, former smokers should continue to seek medical evaluation if persistent respiratory symptoms develop.

Air Pollution

Rapid urbanisation, heavy traffic, construction activities, and industrial emissions contribute to air pollution in Bangalore.

Long-term exposure to fine particulate matter (PM2.5), vehicle exhaust, and other airborne pollutants may increase the risk of chronic respiratory disease and lung cancer, particularly among individuals with additional risk factors.

Occupational Exposure

People employed in information technology campuses generally face lower occupational risks; however, workers in manufacturing, construction, engineering, mining, transport, chemical industries, welding, and heavy engineering may be exposed to:

• Silica dust

• Asbestos

• Diesel exhaust

• Industrial chemicals

• Heavy metals

• Construction dust

Without appropriate protective equipment, prolonged exposure may increase lung cancer risk.

Indoor Air Pollution

Exposure to indoor pollutants such as cooking smoke, poor ventilation, passive smoking, incense smoke, and biomass fuel in some households may contribute to long-term respiratory problems.

Improving indoor ventilation and reducing smoke exposure are important preventive measures.

Previous Lung Diseases

Individuals with chronic respiratory illnesses such as:

• Chronic Obstructive Pulmonary Disease (COPD)

• Pulmonary fibrosis

• Bronchiectasis

• Previous tuberculosis

should seek medical evaluation if persistent respiratory symptoms worsen or fail to improve.

Family History and Genetics

Although most lung cancers are not inherited directly, a family history of lung cancer may increase susceptibility.

Certain genetic mutations also influence tumour behaviour and help doctors determine whether targeted therapy or immunotherapy may be appropriate.

Increasing Age

The likelihood of developing lung cancer generally increases with age because harmful environmental exposures accumulate over many years.

However, younger adults can also develop lung cancer, particularly when genetic or environmental factors are involved.

Understanding the Lungs

The lungs are responsible for supplying oxygen to every organ while removing carbon dioxide from the body.

The right lung contains three lobes, while the left lung contains two lobes to accommodate the heart. Air enters through the trachea, passes into the bronchi, and finally reaches millions of tiny air sacs called alveoli, where oxygen enters the bloodstream.

Because the lungs remain in constant contact with the external environment, they are exposed every day to cigarette smoke, dust, pollution, allergens, industrial chemicals, and infectious organisms. Repeated exposure to these harmful substances may damage the DNA of normal lung cells. If this damage is not repaired successfully, abnormal cells can multiply uncontrollably and eventually form a tumour.

During the early stages, lung cancer may remain confined to the lungs. If left untreated, it can spread through the lymphatic system or bloodstream to nearby lymph nodes and distant organs such as the brain, liver, bones, or adrenal glands. Early diagnosis and timely treatment remain the most important factors for improving long-term outcomes.

What Is Lung Cancer?

Lung cancer is a disease in which abnormal cells within the lungs begin to grow uncontrollably, eventually forming a tumour that interferes with normal breathing and lung function. Unlike healthy cells that grow, divide, and die in an organised manner, cancer cells continue multiplying without control. Over time, these abnormal cells may invade nearby lung tissue, block the airways, spread to nearby lymph nodes, and eventually travel to distant organs such as the brain, liver, bones, or adrenal glands.

The lungs are constantly exposed to the outside environment through every breath we take. Tobacco smoke, air pollution, industrial chemicals, dust particles, and harmful gases can damage the DNA of lung cells. When this damage is not repaired properly, normal cells may become cancerous and begin multiplying uncontrollably.

One of the biggest challenges with lung cancer is that symptoms often develop gradually. Many patients experience no obvious symptoms during the early stages or mistake them for common respiratory infections, allergies, asthma, or pollution-related irritation. As a result, diagnosis may be delayed until the disease has progressed.

Fortunately, advances in modern oncology have transformed lung cancer care. Today, doctors can use advanced imaging, molecular testing, targeted therapy, immunotherapy, minimally invasive procedures, and multidisciplinary cancer care to create highly personalised treatment plans.

Types of Lung Cancer

Lung cancer is classified according to the appearance of cancer cells under the microscope. Determining the exact type is one of the most important steps because treatment and prognosis differ significantly.

The two major categories are:

• Non-Small Cell Lung Cancer (NSCLC)

• Small Cell Lung Cancer (SCLC)

Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer accounts for approximately 85% of all lung cancer cases.

Compared with Small Cell Lung Cancer, NSCLC usually grows more slowly and often offers greater opportunities for surgery or curative treatment when diagnosed early.

NSCLC is divided into three major subtypes.

Adenocarcinoma

Adenocarcinoma is the most common type of lung cancer worldwide and is increasingly diagnosed in people who have never smoked.

It usually develops in the outer portions of the lungs and may remain unnoticed during the early stages.

Common symptoms include:

• Persistent cough

• Breathlessness

• Mild chest discomfort

• Fatigue

• Poor appetite

• Unexplained weight loss

Because adenocarcinoma frequently contains specific genetic mutations, doctors usually recommend molecular testing for:

• EGFR

• ALK

• ROS1

• KRAS

• BRAF

• MET

• RET

The results help determine whether targeted therapy may be beneficial.

Squamous Cell Carcinoma

Squamous Cell Carcinoma develops within the larger airways of the lungs and has a strong association with long-term tobacco use.

Since these tumours often arise near the central bronchi, symptoms may develop earlier.

Patients commonly experience:

• Persistent cough

• Blood in sputum

• Wheezing

• Chest pain

• Recurrent chest infections

• Difficulty breathing

Treatment depends on the stage of disease and may include surgery, chemotherapy, radiation therapy, immunotherapy, or combinations of these treatments.

Large Cell Carcinoma

Large Cell Carcinoma is a relatively uncommon subtype of NSCLC.

It can arise in almost any part of the lung and may grow more rapidly than adenocarcinoma or squamous cell carcinoma.

Treatment recommendations depend on:

• Tumour size

• Stage of disease

• Molecular profile

• Age

• Lung function

• Overall health

Early diagnosis improves the chances of successful treatment.

Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer accounts for approximately 10–15% of all lung cancer cases.

Compared with NSCLC, SCLC usually grows rapidly and often spreads to other organs before symptoms become obvious.

Common sites of spread include:

• Brain

• Liver

• Bones

• Adrenal glands

• Lymph nodes

Although surgery is less commonly performed, chemotherapy, radiation therapy, and immunotherapy remain important treatment options.

Metastatic Lung Cancer

Metastatic lung cancer refers to lung cancer that has spread beyond the lungs to distant organs.

Cancer cells travel through the bloodstream or lymphatic system and establish new tumours in other parts of the body.

Common sites include:

• Brain

• Liver

• Bones

• Adrenal glands

• Distant lymph nodes

Although metastatic disease is more challenging to treat, advances in targeted therapy, immunotherapy, and supportive care have significantly improved quality of life and survival for many patients.

Early Symptoms of Lung Cancer

Symptoms vary depending on the type, size, and location of the tumour.

Some patients experience only mild symptoms during the early stages, while others remain symptom-free until the disease has progressed.

Anyone with persistent respiratory symptoms lasting longer than two to three weeks should seek medical evaluation.

Persistent Cough

A cough that lasts several weeks or gradually worsens is one of the earliest warning signs of lung cancer.

Many people living in metropolitan cities like Bangalore assume that chronic cough is caused by pollution or allergies. However, any persistent cough that does not improve should be medically evaluated.

Coughing Up Blood

Even a small amount of blood in the sputum should never be ignored.

Although infections may occasionally cause blood-stained sputum, lung cancer must always be ruled out.

Immediate medical evaluation is recommended.

Chest Pain

Persistent chest pain may occur when a tumour affects the lung lining or nearby structures.

Patients often report pain that:

• Worsens while coughing

• Increases during deep breathing

• Persists despite medication

• Interferes with normal daily activities

Shortness of Breath

Breathlessness may develop when a tumour blocks an airway, reduces lung capacity, or causes fluid accumulation around the lungs.

Initially, symptoms may occur only during physical activity before gradually worsening.

Wheezing

New-onset wheezing without a previous history of asthma or allergies should always be medically evaluated.

A tumour narrowing the airway may partially block airflow and produce wheezing.

Hoarseness of Voice

Lung tumours located near the nerves controlling the vocal cords may cause:

• Persistent hoarseness

• Voice changes

• Difficulty speaking loudly

Hoarseness lasting longer than three weeks should be assessed by a healthcare professional.

Recurrent Chest Infections

Repeated episodes of pneumonia or bronchitis affecting the same area of the lung may indicate an underlying airway obstruction caused by a tumour.

Prompt investigation is recommended.

Fatigue

Cancer-related fatigue differs from ordinary tiredness.

Patients commonly experience:

• Persistent exhaustion

• Reduced energy levels

• Difficulty performing routine activities

• Poor recovery despite adequate sleep

Unexplained Weight Loss

Unexpected weight loss without changes in diet or physical activity may indicate an underlying medical condition, including lung cancer.

It is often associated with:

• Poor appetite

• Muscle loss

• Weakness

• Reduced physical stamina

Bone Pain

If lung cancer spreads to the bones, patients may develop persistent pain involving:

• Spine

• Ribs

• Shoulder

• Pelvis

• Hip

Persistent bone pain should always be medically evaluated.

Headaches and Neurological Symptoms

When lung cancer spreads to the brain, symptoms may include:

• Persistent headaches

• Dizziness

• Weakness

• Vision changes

• Difficulty walking

• Seizures

These symptoms require urgent medical attention.

Causes and Risk Factors

Lung cancer develops because of a combination of environmental, lifestyle, occupational, and genetic factors.

Major risk factors include:

• Cigarette smoking

• Beedi smoking

• Hookah smoking

• Second-hand smoke

• Air pollution

• Industrial emissions

• Construction dust

• Silica exposure

• Asbestos

• Diesel exhaust

• Indoor air pollution

• Previous tuberculosis

• COPD

• Pulmonary fibrosis

• Family history of lung cancer

• Increasing age

• Genetic mutations

For people living in Bangalore and across Karnataka, prolonged exposure to urban air pollution, traffic emissions, construction dust, industrial chemicals, and occupational hazards may contribute to respiratory health risks alongside tobacco use.

Who Is at Higher Risk?

The following individuals should pay particular attention to persistent respiratory symptoms:

• Current smokers

• Former smokers

• Adults above 50 years of age

• People exposed to second-hand smoke

• Workers in construction, manufacturing, mining, transport, engineering, welding, and chemical industries

• Individuals with COPD or previous tuberculosis

• People with a family history of lung cancer

• Residents exposed to prolonged urban air pollution or occupational dust

Being at higher risk does not necessarily mean a person will develop lung cancer. However, recognising these risk factors encourages earlier medical evaluation, timely diagnosis, and access to appropriate treatment when needed.

When Should You Consult a Lung Cancer Specialist?

Many people ignore persistent respiratory symptoms because they believe they are caused by seasonal allergies, pollution, smoking, ageing, or common respiratory infections. Unfortunately, delaying medical evaluation may allow lung cancer to progress before it is diagnosed.

Early diagnosis remains one of the most important factors influencing successful treatment. Patients diagnosed during the early stages generally have more treatment options and better long-term outcomes than those diagnosed after the disease has spread.

If you live in Bangalore, Mysuru, Mangaluru, Hubballi, Belagavi, Tumakuru, Shivamogga, Ballari, Davanagere, Hassan, Udupi, or nearby regions, you should consult a doctor if you experience:

• A cough lasting longer than three weeks

• Coughing up blood

• Persistent chest pain

• Increasing shortness of breath

• Hoarseness of voice

• Wheezing without asthma

• Recurrent pneumonia or chest infections

• Unexplained weight loss

• Persistent fatigue

• Bone pain or headaches associated with respiratory symptoms

Seeking medical advice does not necessarily mean you have lung cancer. However, prompt evaluation helps identify the underlying cause and allows treatment to begin as early as possible if cancer is diagnosed.

How Is Lung Cancer Diagnosed?

Modern lung cancer diagnosis involves much more than identifying an abnormal shadow on a chest X-ray. Specialists use advanced imaging, tissue biopsy, pathology, molecular testing, and multidisciplinary assessment to accurately diagnose the disease and recommend the most appropriate treatment.

Patients from Bangalore can complete most investigations locally before seeking an expert review or second opinion.

Medical History and Physical Examination

Every consultation begins with a detailed discussion about your symptoms and medical history.

Your doctor may ask about:

• Duration and progression of symptoms

• Smoking or tobacco history

• Exposure to second-hand smoke

• Occupational exposure to dust or chemicals

• Previous tuberculosis or chronic lung disease

• Family history of cancer

• Weight loss or appetite changes

• Current medications

• Previous cancer treatments

• Other medical conditions

A physical examination may identify enlarged lymph nodes, abnormal breathing sounds, reduced oxygen levels, or other findings requiring further investigation.

Chest X-ray

A chest X-ray is usually the first imaging investigation when lung cancer is suspected.

Although it cannot diagnose every lung tumour, it helps identify abnormalities such as:

• Lung masses

• Persistent pneumonia

• Lung collapse

• Fluid around the lungs

• Enlarged lymph nodes

If an abnormality is detected, further imaging is generally recommended.

CT Scan (Computed Tomography)

A CT scan provides detailed cross-sectional images of the lungs and surrounding structures.

Compared with a standard chest X-ray, CT scanning provides much more information regarding:

• Exact tumour location

• Tumour size

• Airway involvement

• Blood vessel involvement

• Enlarged lymph nodes

• Spread within the chest

CT imaging also helps specialists determine whether surgery, biopsy, or additional investigations are required.

PET-CT Scan

PET-CT combines Positron Emission Tomography (PET) with Computed Tomography (CT).

Before the scan, a small amount of radioactive glucose is injected into the bloodstream. Cancer cells consume more glucose than normal tissues, making them appear as areas of increased metabolic activity.

PET-CT helps determine:

• Whether cancer has spread beyond the lungs

• Lymph node involvement

• Suitability for surgery

• Response to treatment

• Possible recurrence after treatment

PET-CT has become one of the most valuable investigations for accurately staging lung cancer.

MRI Scan

MRI is recommended when doctors suspect that lung cancer has spread to the brain, spine, or other soft tissues.

MRI provides detailed images of the nervous system and is particularly useful for patients experiencing:

• Persistent headaches

• Dizziness

• Weakness

• Vision problems

• Difficulty walking

• Seizures

Bronchoscopy

Bronchoscopy is a minimally invasive procedure that allows specialists to examine the inside of the airways using a flexible camera.

During bronchoscopy, doctors can:

• Examine the airways

• Identify abnormal growths

• Collect tissue samples

• Assess airway narrowing

• Remove secretions when necessary

The procedure is generally performed under sedation, and most patients return home on the same day.

Endobronchial Ultrasound (EBUS)

Endobronchial Ultrasound combines bronchoscopy with ultrasound imaging.

This advanced procedure enables specialists to examine lymph nodes deep within the chest and obtain biopsy samples without major surgery.

EBUS plays a vital role in accurate staging and treatment planning.

CT-Guided Needle Biopsy

When a tumour is located near the outer portion of the lung, a CT-guided needle biopsy may be recommended.

Using CT imaging for guidance, a specialised needle is inserted through the chest wall to obtain a tissue sample.

The sample is then examined by a pathologist to confirm the diagnosis.

Histopathology

A biopsy remains the gold standard for confirming lung cancer.

The pathology report provides detailed information regarding:

• Type of lung cancer

• Tumour grade

• Cell characteristics

• Additional microscopic findings that influence treatment planning

Without biopsy confirmation, a definitive diagnosis generally cannot be established.

Molecular Testing

One of the greatest advances in modern lung cancer care is molecular profiling.

Instead of identifying cancer only by its microscopic appearance, specialists analyse specific genetic alterations within tumour cells.

Common biomarkers include:

• EGFR

• ALK

• ROS1

• KRAS

• BRAF

• MET

• RET

• NTRK

• PD-L1

Patients with these biomarkers may benefit from targeted therapy or immunotherapy.

Molecular testing has become an essential part of personalised treatment planning for many patients with Non-Small Cell Lung Cancer.

Liquid Biopsy

Liquid biopsy is an advanced blood test that detects tumour DNA circulating in the bloodstream.

It may be useful:

• When tissue biopsy is difficult

• To identify additional genetic mutations

• To monitor treatment response

• To evaluate suspected recurrence

Although not appropriate for every patient, liquid biopsy has become an increasingly valuable tool in precision oncology.

Understanding Lung Cancer Staging

After lung cancer has been confirmed, specialists determine how far the disease has spread.

This process is known as staging.

Accurate staging is essential because treatment recommendations differ significantly between early-stage and advanced disease.

Stage 0

Cancer cells remain confined to the inner lining of the airways without invading deeper tissues.

Treatment at this stage often provides excellent long-term outcomes.

Stage I

The tumour remains confined to the lung without lymph node involvement.

Many patients diagnosed at this stage are suitable candidates for surgery or other treatments with curative intent.

Stage II

The tumour may be larger or involve nearby lymph nodes.

Treatment often includes surgery followed by chemotherapy and, in selected patients, radiation therapy.

Stage III

Cancer has spread to lymph nodes within the chest or nearby structures.

Treatment usually combines:

• Chemotherapy

• Radiation therapy

• Immunotherapy

• Surgery in carefully selected patients

Management generally involves discussion by a multidisciplinary oncology team.

Stage IV

Stage IV lung cancer indicates that the disease has spread beyond the lungs to distant organs such as the brain, liver, bones, or adrenal glands.

Although Stage IV disease is generally not considered curable, advances in targeted therapy, immunotherapy, chemotherapy, and supportive care have significantly improved survival and quality of life for many patients.

Personalised Treatment Planning

No two lung cancer patients are exactly alike.

Every treatment recommendation is based on:

• Type of lung cancer

• Stage of disease

• Molecular profile

• Patient’s age

• Overall health

• Lung function

• Previous treatments

• Individual treatment goals

Patients from Bangalore and across Karnataka seeking a second opinion through Fuda Cancer Hospital can have their CT scans, PET-CT images, biopsy reports, pathology findings, and molecular testing reviewed by an experienced multidisciplinary oncology team. This collaborative approach helps ensure that every patient receives an evidence-based, personalised treatment plan tailored to their diagnosis, overall health, and treatment goals before therapy begins.

Advanced Treatment Options for Lung Cancer

Over the past two decades, lung cancer treatment has advanced significantly. Today, treatment is highly personalised and based on several important factors, including the type of lung cancer, stage of disease, molecular profile, lung function, age, overall health, and the patient’s treatment goals.

For patients from Bangalore, Mysuru, Mangaluru, Hubballi, Belagavi, Tumakuru, Shivamogga, Ballari, Davanagere, Udupi, Hassan, and across Karnataka, modern oncology offers multiple treatment options that may be used individually or in combination. Every patient’s case is reviewed carefully to determine the most appropriate treatment strategy.

Surgery for Lung Cancer

Surgery remains one of the most effective treatments for patients diagnosed with early-stage Non-Small Cell Lung Cancer (NSCLC). The aim is to remove the tumour completely while preserving as much healthy lung tissue as possible.

Before recommending surgery, specialists carefully evaluate:

• Stage of disease

• Tumour size and location

• Lung function

• Heart health

• Overall physical fitness

• Existing medical conditions

Types of Lung Cancer Surgery

Wedge Resection

A wedge resection removes the tumour together with a small margin of surrounding healthy lung tissue. This procedure may be appropriate for very small tumours or for patients with reduced lung function.

Segmentectomy

A segmentectomy removes one anatomical segment of the lung while preserving the remaining healthy lung tissue. It may be recommended for selected patients with early-stage disease.

Lobectomy

Lobectomy involves removal of one complete lobe of the lung and remains the standard surgical treatment for many early-stage lung cancers.

Pneumonectomy

When the tumour involves a large portion of the lung or major airways, removal of the entire lung may occasionally be required. Although it is a major operation, many patients recover well with pulmonary rehabilitation and long-term follow-up.

Chemotherapy

Chemotherapy uses specialised anti-cancer medicines to destroy rapidly growing cancer cells throughout the body.

Chemotherapy may be recommended:

• Before surgery (Neoadjuvant Chemotherapy)

• After surgery (Adjuvant Chemotherapy)

• Along with radiation therapy

• For advanced or metastatic lung cancer

• To reduce symptoms and improve quality of life

Treatment is generally administered in cycles, allowing adequate recovery between sessions.

Possible Side Effects

Modern supportive medications have significantly improved the management of chemotherapy-related side effects.

Some patients may experience:

• Fatigue

• Nausea and vomiting

• Temporary hair loss

• Reduced immunity

• Mouth ulcers

• Loss of appetite

• Tingling or numbness in the hands and feet

Many of these side effects are temporary and manageable with appropriate supportive care.

Radiation Therapy

Radiation therapy uses precisely targeted high-energy radiation beams to destroy cancer cells while minimising damage to surrounding healthy tissues.

Radiation therapy may be recommended:

• When surgery is not suitable

• Before surgery to reduce tumour size

• After surgery to decrease recurrence risk

• Combined with chemotherapy

• To relieve symptoms in advanced disease

Modern Radiation Techniques

Intensity-Modulated Radiation Therapy (IMRT)

IMRT delivers radiation from multiple angles while adjusting beam intensity to maximise tumour control and minimise radiation exposure to nearby healthy organs.

Stereotactic Body Radiation Therapy (SBRT)

SBRT delivers highly focused, high-dose radiation over a limited number of treatment sessions. It may be suitable for selected patients with small, localised tumours who are not candidates for surgery.

Targeted Therapy

Targeted therapy has transformed the treatment of many patients with Non-Small Cell Lung Cancer.

Unlike chemotherapy, targeted therapy specifically attacks cancer cells carrying particular genetic mutations while reducing damage to many healthy cells.

Before treatment begins, molecular testing helps identify biomarkers including:

• EGFR

• ALK

• ROS1

• KRAS

• BRAF

• MET

• RET

• NTRK

Patients with these mutations may benefit from precision medicines specifically designed for these genetic alterations.

Advantages of Targeted Therapy

• Personalised treatment approach

• Often available as oral medication

• Different side-effect profile compared with chemotherapy

• Effective disease control in selected patients

Immunotherapy

Immunotherapy is one of the most significant advances in modern cancer care.

Instead of directly attacking cancer cells, immunotherapy helps the body’s immune system recognise and destroy them more effectively.

Doctors often perform PD-L1 testing or other biomarker assessments before recommending immunotherapy.

Immunotherapy may be used:

• Alone

• Combined with chemotherapy

• Following chemotherapy and radiation therapy

• For advanced lung cancer

• In selected patients after surgery

Cryotherapy (Cryosurgery)

Cryotherapy, also known as Cryoablation, is a minimally invasive procedure that destroys selected tumours using extremely low temperatures.

Using advanced imaging guidance, a specialised probe is positioned within or near the tumour. Controlled freezing and thawing cycles destroy cancer cells while preserving much of the surrounding healthy tissue.

Potential advantages include:

• Minimally invasive treatment

• Reduced blood loss

• Smaller incisions

• Faster recovery

• Preservation of healthy lung tissue in selected patients

Suitability depends on tumour size, location, and the patient’s overall clinical condition.

NanoKnife Irreversible Electroporation (IRE)

NanoKnife IRE is an advanced treatment that uses carefully controlled electrical pulses rather than heat or freezing to destroy selected tumours.

The electrical pulses create microscopic openings in cancer cell membranes, leading to cell death while helping preserve nearby blood vessels, nerves, and other important structures.

NanoKnife IRE may be considered for carefully selected patients whose tumours are located close to vital anatomical structures.

Recovery and Rehabilitation

Recovery following lung cancer treatment depends on the type of treatment received and the patient’s overall health.

Recovery programmes may include:

• Pulmonary rehabilitation

• Breathing exercises

• Gradual increase in physical activity

• Smoking cessation support

• Nutritional counselling

• Regular follow-up imaging

• Symptom monitoring

• Emotional support

A structured rehabilitation programme often helps patients improve lung function, reduce fatigue, and regain independence.

Nutrition During Lung Cancer Treatment

Maintaining good nutrition helps support healing, preserve muscle strength, and improve tolerance to treatment.

General dietary recommendations include:

• Eat small, frequent meals.

• Include protein-rich foods such as eggs, fish, pulses, paneer, tofu, lean meat, and dairy products.

• Eat a variety of fresh fruits and vegetables.

• Stay well hydrated.

• Limit processed foods and excessive sugar intake.

• Consult a clinical dietitian if appetite decreases or swallowing becomes difficult.

Why Bangalore Patients Choose Fuda Cancer Hospital

Patients from Bangalore and across Karnataka often seek expert guidance to better understand their diagnosis and explore advanced treatment options.

Through its collaboration with Rekosh Health Care, Fuda Cancer Hospital offers:

• Expert second opinions

• Multidisciplinary case reviews

• Personalised treatment planning

• Review of CT scans, PET-CT scans, biopsy reports, and pathology findings

• Guidance on advanced therapies

• Consultation support through Mumbai and Noida centres

• Long-term follow-up coordination

Treatment Journey for Patients from Bangalore

Step 1 – Book an Expert Consultation

Patients can begin with an online or in-person consultation to discuss their diagnosis, symptoms, and previous treatments.

Step 2 – Submit Medical Reports

The oncology team reviews:

• CT scans

• PET-CT scans

• MRI reports

• Bronchoscopy findings

• Biopsy reports

• Histopathology reports

• Molecular testing reports

• Previous treatment records

Step 3 – Multidisciplinary Case Review

Specialists evaluate the type of cancer, stage, molecular profile, lung function, and overall health before preparing a personalised treatment recommendation.

Step 4 – Individualised Treatment Planning

Depending on the diagnosis, treatment may include:

• Surgery

• Chemotherapy

• Radiation Therapy

• Targeted Therapy

• Immunotherapy

• Cryotherapy

• NanoKnife IRE

• Supportive and palliative care

Step 5 – Long-Term Follow-up

Patients continue with scheduled reviews, imaging, pulmonary rehabilitation, nutritional counselling, and supportive care to monitor recovery and detect recurrence early.

Lung Cancer Treatment Cost in Bangalore

Treatment costs vary depending on the stage of disease, investigations required, medications, hospital stay, and treatment approach.

Actual treatment costs depend on the patient’s diagnosis, treatment plan, medications, duration of care, and hospital stay.

Prevention Tips

Although not every case of lung cancer can be prevented, the following measures may help reduce the overall risk:

• Stop smoking and avoid all tobacco products.

• Avoid exposure to second-hand smoke.

• Reduce exposure to air pollution and occupational dust.

• Wear appropriate respiratory protection when working in environments with silica, chemicals, or industrial dust.

• Maintain a healthy diet and regular physical activity.

• Seek medical evaluation for persistent respiratory symptoms.

• Attend regular health check-ups if you have significant risk factors.

Frequently Asked Questions

1. Can non-smokers develop lung cancer?

Yes. Lung cancer can occur in non-smokers due to genetic factors, air pollution, passive smoking, occupational exposure, or previous lung diseases.

2. What are the earliest symptoms of lung cancer?

Persistent cough, breathlessness, chest pain, coughing up blood, fatigue, hoarseness, repeated chest infections, and unexplained weight loss.

3. Is lung cancer curable?

Some early-stage lung cancers can be treated with curative intent. The outcome depends on the cancer type, stage, and response to treatment.

4. Is surgery required for every patient?

No. Treatment depends on the type and stage of lung cancer. Many patients receive chemotherapy, radiation therapy, targeted therapy, immunotherapy, or combinations of these treatments.

5. What is molecular testing?

Molecular testing identifies genetic mutations such as EGFR, ALK, ROS1, and others that help doctors determine whether targeted therapy is appropriate.

6. What is immunotherapy?

Immunotherapy helps the body’s immune system recognise and attack cancer cells and may be recommended for eligible patients.

7. What is Cryotherapy?

Cryotherapy is a minimally invasive procedure that destroys selected tumours using extremely low temperatures.

8. What is NanoKnife IRE?

NanoKnife IRE uses electrical pulses to destroy selected tumours while helping preserve nearby blood vessels and nerves.

9. Can I seek a second opinion before starting treatment?

Yes. Many patients choose to seek a second opinion to better understand their diagnosis and explore all available treatment options before beginning therapy.

10. Can treatment planning begin after an online consultation?

Yes. Patients can begin by sharing their medical reports online, allowing specialists to review the case and recommend appropriate investigations or treatment before an in-person visit if required.

Conclusion

Advances in lung cancer diagnosis and treatment have created more opportunities for personalised care than ever before. Early diagnosis, accurate staging, molecular testing, and multidisciplinary treatment planning enable doctors to select therapies that are most appropriate for each patient’s condition.

For patients in Bangalore and across Karnataka, timely consultation and expert guidance can make a significant difference. Whether you have recently been diagnosed, are seeking a second opinion, or wish to explore advanced treatment options, discussing your case with an experienced oncology team can help you make informed decisions with confidence.

Schedule Your Consultation

If you or a loved one has been diagnosed with lung cancer, you can begin by requesting an expert consultation through Rekosh Health Care, the India partner supporting patient coordination with Fuda Cancer Hospital.

The team can assist with:

• Expert second opinions

• Medical report review

• Personalised treatment planning

• Guidance on advanced treatment options

• Coordination of consultations and follow-up care

Early consultation and timely medical evaluation can help you better understand your diagnosis and explore the most appropriate treatment options for your individual condition.